Effects of an Engineered Human Anti–TNF-α Antibody (CDP571) on Insulin Sensitivity and Glycemic Control in Patients With NIDDM
Inhibition of tumor necrosis factor (TNF)-α action has recently been shown to reverse insulin resistance dramatically and to improve glycemic control in obese rodents. This doub...